Company intelligence / Profile preview

RoslinCT

Edinburgh, Scotland, United Kingdomroslinct.com ↗
Ownership
Private
Employees
~200
Development stage
Commercial
01

Overview

RoslinCT is a leading global CDMO specializing in advanced cell and gene therapies. It was one of the first organizations to produce clinical-grade human pluripotent stem cells and has supported the development of the first CRISPR-edited cell therapy product for an inherited disorder. The company provides process development, analytical services, cGMP manufacturing for both autologous/allogeneic products across multiple therapeutic modalities. It operates state-of-the-art facilities in Edinburgh (UK) and Hopkinton, Massachusetts (US), serving international pharma/biotech clients from early-stage to commercial production.

Therapeutic areas
Other
Modalities
Cell therapyGene therapyInduced pluripotent stem cell derived therapyCAR-T cell therapyNK cell therapyMesenchymal stem cell therapyHematopoietic stem cell therapyAllogeneic therapiesAutologous therapies
Industry
Contract Manufacturing Organization
02

Partnerships

Works with "blue-chip Pharma and Biotech companies" globally on contract basis; specific names are confidential/not disclosed publicly.

Beyond the preview

Go deeper on RoslinCT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RoslinCT.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call